COVID-19: Russia to start mass inoculation of vaccine this month as it insists on its safety
The vaccine is said to be undergoing Phase 3 trials, which is the final stage.
The vaccine is said to be undergoing Phase 3 trials, which is the final stage.
The vaccine produced an immune response in early-stage clinical trials with no major side effect.
The results encouraged moving to a larger clinical trial to test if the vaccine is actually safe.